IAPD status | Total participants | T2DM n (%) | Relative risk (95% CI) | ||||
Model 1* | Model 2† | Model 3‡ | Model 4§ | Model 5¶ | |||
Persistent no IAPD | 125 | 10 (8.0) | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Incident IAPD | 63 | 21 (33.3) | 4.17 (2.09 to 8.30)*** | 3.78 (1.89 to 7.54)*** | 4.31 (2.00 to 9.27)*** | 4.17 (1.93 to 9.00)*** | 3.69 (1.76 to 7.71)*** |
Persistent IAPD | 266 | 68 (25.6) | 3.20 (1.70 to 5.99)*** | 3.01 (1.60 to 5.65)*** | 3.33 (1.65 to 6.71)*** | 3.27 (1.62 to 6.61)*** | 3.27 (1.64 to 6.50)*** |
Remittent IAPD | 120 | 14 (11.7) | 1.46 (0.67 to 3.16) | 1.49 (0.69 to 3.21) | 2.00 (0.88 to 4.56) | 2.05 (0.89 to 4.68) | 2.24 (0.99 to 5.11) |
***p<0.001.
*Model 1: unadjusted model.
†Model 2: adjusted for age and sex at baseline (visit 1).
‡Model 3: adjusted for variables in model 2 plus body mass index, systolic blood pressure, and diastolic blood pressure at baseline (visit 1).
§Model 4: adjusted for variables in model 3 plus creatinine, cholesterol, high-density lipoproteins (HDL), low-density lipoproteins (LDL), triglycerides, and alanine aminotransferase at baseline (visit 1).
¶Model 5: adjusted for variables in model 4 plus fasting plasma glucose at baseline (visit 1).